Efficacy of Neoveil covering ESD by novel Device Delivery Station System (DDSS) compared to Conventional Neoveil-ESD(CN-ESD) in Neoveil placement time: a randomized prospective study

Efficacy of Neoveil covering ESD by novel Device Delivery Station System (DDSS) compared to Conventional Neoveil-ESD(CN-ESD) in Neoveil placement time: a randomized prospective study - Novel Device Delivery Station System (DDSS)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026377

Enrollment

Registered

2017-03-03

Start date

2017-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early differentiated gastric cancer over 20 mm in diameter

Interventions

Novel Device Delivery Station System (DDSS) Conventinal ESD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Early differentiated gastric cancer over 20 mm in diameter diagnosed with narrow band imaging magnified endoscopy and biopsy.

Exclusion criteria

Exclusion criteria: Exclusion criteria of definite advanced gastric cancer.

Design outcomes

Primary

Measure	Time frame
Difference of covering time between CN-ESD group and DDSS-ESD group	—

Secondary

Measure	Time frame
1.Post ESD bleeding 2.Post ESD perforation 3.Post ESD Deformity and stasis	—

Countries

Japan

Contacts

Public ContactHirohito Mori

Ehime Rosai Hospital Department of Gastroenterology

hiro4884@med.kagawa-u.ac.jp0897-33-6191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026